Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06091527

Treating Major Depression With Yoga Mono-therapy

Treating Major Depression With Yoga Mono-therapy: 12-Week Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.

Detailed description

Consenting participants will be randomized equally to one of three in-person group interventions for 12 weeks: Standard yoga practice, Ayurvedic yoga practice, or educational attention-control modules. The primary outcome is depression severity, measured by Beck Depression Inventory-II (BDI) scores. Secondary outcomes include perceived stress, measured by Perceived Stress Scale (PSS) scores, and several biomarker assays associated with depression: methylation of the GrimAge epigenetic clock, nuclear factor kappa-B (NF-κB) transcription, leucocyte telomere length, interleukin-6 (IL-6) and brain-derived neurotropic factor (BDNF). Blinded assessors will conduct all outcome analyses at 12 weeks. The primary analysis will test whether the yoga groups combined achieve statistically greater change in BDI scores compared to the control group. Secondary analyses will test whether the yoga groups combined, compared to the control group, demonstrate statistically greater change in PSS scores and the aforementioned biomarker assays. In sub-analyses, investigators will assess whether Ayurvedic yoga participants, compared to Standard yoga participants, demonstrate statistically significant improvements in BDI scores, PSS scores, and depression biomarker assays over the 12-week intervention period.

Conditions

Interventions

TypeNameDescription
BEHAVIORALYoga practice90-minute group yoga classes twice weekly for 12 weeks.
BEHAVIORALEducation90-minute group education classes twice weekly for 12 weeks to learn holistic healthcare modules.

Timeline

Start date
2024-10-25
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2023-10-19
Last updated
2025-11-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06091527. Inclusion in this directory is not an endorsement.